Literature DB >> 22553668

Vitrectomy for vitreous amyloidosis.

Jiang You1.   

Abstract

AIM: To study the clinical features of vitreous amyloidosis and the effect of vitrectomy for it.
METHODS: We treated 6 eyes (4 Patients) with vitreous amyloidosis from 2008 to 2009, and followed up for 18-30 months after vitrectomy.
RESULTS: The visual acuity ranged from counting fingers to 3/50 before surgery and 15/50-40/50 after vitrectomy. No severe complication was observed.
CONCLUSION: Vitrectomy is an effective and safe treatment for eyes with vitreous amyloidosis. A long period of follow-up after surgery should be performed.

Entities:  

Keywords:  surgical treatment; vitreous amyloidosis

Year:  2011        PMID: 22553668      PMCID: PMC3340815          DOI: 10.3980/j.issn.2222-3959.2011.03.20

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  21 in total

1.  Primary non familial amyloidosis of the vitreous and subretinal amyloid bodies.

Authors:  G Rosenthal; P Walter; K U Bartz-Schmidt; K Heimann
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

2.  Vitreous amyloidosis in alanine 71 transthyretin mutation.

Authors:  H J Zambarakji; D G Charteris; W Ayliffe; P J Luthert; F Schon; P N Hawkins
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

3.  Amyloid deposition in ocular tissues of patients with familial amyloidotic polyneuropathy (FAP).

Authors:  Katsuki Haraoka; Yukio Ando; Eiko Ando; Ole Sandgren; Akira Hirata; Masaaki Nakamura; Hisayasu Terazaki; Takahiro Tajiri; Yutaka Tanoue; Xuguo Sun; Hiroaki Okabe; Hidenobu Tanihara
Journal:  Amyloid       Date:  2002-09       Impact factor: 7.141

Review 4.  Transthyretin-related familial amyloidotic polyneuropathy.

Authors:  Yukio Ando; Masaaki Nakamura; Shukuro Araki
Journal:  Arch Neurol       Date:  2005-07

5.  Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients.

Authors:  Ryuhei Hara; Takahiro Kawaji; Eiko Ando; Yuki Ohya; Yukio Ando; Hidenobu Tanihara
Journal:  Arch Ophthalmol       Date:  2010-02

6.  A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy.

Authors:  Takahiro Kawaji; Yukio Ando; Eiko Ando; Masaaki Nakamura; Akira Hirata; Hidenobu Tanihara
Journal:  Amyloid       Date:  2004-12       Impact factor: 7.141

7.  [Transthyretin Arg-83 mutation in vitreous amyloidosis].

Authors:  Lingyan Chen; Lin Lü; Ping Zhang; Yonghao Li; Jianxian Lin
Journal:  Yan Ke Xue Bao       Date:  2008-03

8.  Amyloidosis of the vitreous. Fluorescein angiographic findings and association with neovascularization.

Authors:  D J Savage; C A Mango; B W Streeten
Journal:  Arch Ophthalmol       Date:  1982-11

9.  Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy.

Authors:  Takahisa Koga; Eiko Ando; Akira Hirata; Mikiko Fukushima; Akira Kimura; Yukio Ando; Akira Negi; Hidenobu Tanihara
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

View more
  2 in total

1.  Reply to: "Bilateral Non-arteritic Anterior Ischaemic Optic Neuropathy as the Presentation of Systemic Amyloidosis".

Authors:  Francesco Pellegrini; Daniele Cirone; Luca De Simone; Luca Cimino; Cristina Ciabattoni
Journal:  Neuroophthalmology       Date:  2017-09-27

Review 2.  Ocular Involvement in Hereditary Amyloidosis.

Authors:  Angelo Maria Minnella; Roberta Rissotto; Elena Antoniazzi; Marco Di Girolamo; Marco Luigetti; Martina Maceroni; Daniela Bacherini; Benedetto Falsini; Stanislao Rizzo; Laura Obici
Journal:  Genes (Basel)       Date:  2021-06-22       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.